Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2912411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Weidong Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Psoriasis, Mesenchymal Stem Cells, Interferon-gamma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Natural Science Foundation, Suzhou Basic Research Pilot Project, Bo Xi Foundation.
Abstract (Originalsprache)
Background
Psoriasis is a chronic and incurable skin inflammation driven by an abnormal immune response. Our study aims to investigate the potential of interferon-γ (IFN-γ) primed mesenchymal stem cells (IMSCs) in targeting T cells to attenuate psoriasis-like inflammation, and to elucidate the underlying molecular mechanism involved.
Methods
Mesenchymal stem cells (MSCs) were isolated from the umbilical cord and identified based on their surface markers. Psoriasis models were established and then treated with IMSCs. Flow cytometry analysis was used to examine cell surface markers and T cell percentages. Indoleamine-2,3-dioxygenase (IDO) was knocked down by small interfering RNA (siRNA) and examined with western blot assay. The proliferative capacity of T cells was assessed using water-soluble tetrazolium salt-1(WST-1). Additionally, an immunohistochemical assay was used to determine epidermal thickness. The psoriasis area and severity index (PASI) scores were also assessed.
Results
We observed significant therapeutic efficacy of IMSCs against psoriasis-like inflammation in mice. Treatment with IMSCs resulted in a notable reduction in T cell infiltration within psoriatic lesions. Furthermore, we demonstrated that the therapeutic efficacy was mediated by the upregulation of IDO through IFN-γ stimulation. In vitro, IDO inhibited T cell proliferation, and in vivo, the therapeutic efficacy was eliminated when MSCs were transfected with IDO siRNA.
Conclusion
IMSCs can treat psoriasis by suppressing T cell infiltration and the suppression is mediated by IDO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital of Soochow University, 215123 Suzhou, Jiangsu, China.
- Department of Dermatology and Venereology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, 215123 Suzhou, Jiangsu, China.
Förderung
- Jiangsu Provincial Natural Science Foundation
- Suzhou Basic Research Pilot Project
- Bo Xi Foundation
- Science and Technology Development Foundation of Nanjing Medical University
- Suzhou Science and Technology Bureau Project
Zitieren
APA
Zhu, W., Qi, C., Shi, C., Yang, H., Shi, F., & Ding, Y. (2024). Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2912411
Vancouver
Zhu W, Qi C, Shi C, Yang H, Shi F, Ding Y. Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2912411
BibTeX
@article{Zhu2024,
author = {Zhu, Weidong and Qi, Chang and Shi, Chenxi and Yang, Hongli and Shi, Feng and Ding, Yayun},
title = {Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2912411}
}
EUVIMED